The Patent Finder

Innatus Corporation

Also on record
Records under this name other than patents Innatus Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 5 of 5 · Back to Innatus Corporation

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,854,717Method and compositions for treatment of cancers
Lapsed on the fee record
Ended Dec 21, 2022 · USPTO record
Lapsed on the fee recordEnded Dec 21, 2022USPTO record
US 8,197,430Method and system to remove cytokine inhibitor in patients
Lapsed on the fee record
Ended Jun 12, 2020 · USPTO record
Lapsed on the fee recordEnded Jun 12, 2020USPTO record
US 8,133,490Method and system to remove cytokine inhibitors in patients
Term ended
Term ended Feb 21, 2020 · USPTO record
Term endedTerm ended Feb 21, 2020USPTO record
US 6,231,536Method and compositions for treatments of cancers
Term ended
Term ended May 21, 2019 · USPTO record
Term endedTerm ended May 21, 2019USPTO record
US 6,620,382Method and compositions for treatment of cancers
Term ended
Term ended May 22, 2018 · USPTO record
Term endedTerm ended May 22, 2018USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited